How First World Scientists Can Reach Out To Third World Colleagues

Turn to the “Tools” or “New Products” pages of The Scientist and you will discover splendid state-of-the-art instruments, many of which carry rather hefty price tags. It’s hard not to notice that the cost of doing science has been rising precipitously. The reason? For one, scientific investigations are increasingly more detailed or far-reaching, requiring more complex and powerful instruments. Many universities and companies in the U.S. can afford the latest equip

Written byEugene Garfield
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Turn to the “Tools” or “New Products” pages of The Scientist and you will discover splendid state-of-the-art instruments, many of which carry rather hefty price tags. It’s hard not to notice that the cost of doing science has been rising precipitously. The reason? For one, scientific investigations are increasingly more detailed or far-reaching, requiring more complex and powerful instruments.

Many universities and companies in the U.S. can afford the latest equipment. But expensive instruments are, in many instances, simply beyond the reach of our Third World colleagues. These scientists typically must make do with equipment that is 20 or more years old. In many developing and Eastern Bloc nations, the absence of instruments and supplies has led to a tradition of excellence in theoretical work. And in Latin America and Africa, scientists have taken up subjects of local consequence relating to agriculture, many of which do not require sophisticated equipment.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies